Results 251 to 260 of about 42,548 (287)

Fundus Autofluorescence in Geographic Atrophy: A Review

Seminars in Ophthalmology, 2010
Fundus autofluorescence is a noninvasive imaging technology that provides information on the distribution of lipofuscin within the retinal pigment epithelial cell monolayer. Progressive accumulation of lipofuscin within retinal pigment epithelial cells is involved in the pathogenesis of geographic atrophy in age-related macular degeneration.
Netan, Choudhry, Andrea, Giani, Joan W, Miller   +2 more
openaire   +2 more sources

Outer Retinal Tubulation in Geographic Atrophy

Ophthalmic Surgery, Lasers and Imaging Retina
Background and Objective: Outer retinal tubulation (ORT) is observed on optical coherence tomography images from patients with geographic atrophy (GA), but its clinical implications are unclear. The objective of this study was to investigate the prevalence of ORT and its association with GA lesion growth rates.
Kensington A, Hatcher, Birva K, Shah, Mark, Burch, Srinivas Sai A, Kondapalli, Caroline R, Baumal   +4 more
openaire   +2 more sources

Progression of geographic atrophy

Expert Review of Ophthalmology, 2021
Federico Corvi, SriniVas R. Sadda
openaire   +1 more source

Geographic Atrophy

2013
Elisabetta Pilotto, Francesca Guidolin
openaire   +2 more sources

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Lancet, The, 2023
Frank G Holz, Philip J Rosenfeld, Jean-François Korobelnik   +2 more
exaly  

EXPANDING THE UNDERSTANDING OF GEOGRAPHIC ATROPHY

Retina, 2022
openaire   +2 more sources

Comparison of Fundus Autofluorescence Versus Optical Coherence Tomography–based Evaluation of the Therapeutic Response to Pegcetacoplan in Geographic Atrophy

American Journal of Ophthalmology, 2022
Julia Mai, Sophie Riedl, Gregor S Reiter   +2 more
exaly  

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Lancet, The, 2023
David A Eichenbaum, Jason Hsu, Glenn J Jaffé   +2 more
exaly  

Atrophy, Geographic

2014
Moritz Lindner, Monika Fleckenstein, Steffen Schmitz-Valckenberg, Frank G. Holz   +3 more
openaire   +1 more source

The Effect of Pegcetacoplan Treatment on Photoreceptor Maintenance in Geographic Atrophy Monitored by Artificial Intelligence–Based OCT Analysis

Ophthalmology Retina, 2022
Sophie Riedl, Wolf-Dieter Vogl, Julia Mai   +2 more
exaly